Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Department of Respiratory Medicine, Kurihara Central Hospital, Kurihara 987-2205, Japan.
Int J Chron Obstruct Pulmon Dis. 2020 Apr 22;15:857-868. doi: 10.2147/COPD.S238457. eCollection 2020.
Different characteristics of patients with chronic obstructive pulmonary disease (COPD) between Western and Japanese populations have been reported. Risk factors for COPD exacerbation have been reported in Western countries but have not been studied in Japan.
We retrospectively examined risk factors for COPD exacerbation. A total of 156 Japanese patients were enrolled, and the records of 136 patients were analyzed.
In the exacerbation group (n=60), body mass index, forced vital capacity (FVC), forced expiratory volume in one second (FEV), the FEV/FVC ratio (FEV/FVC), the percent predicted values of FEV (%FEV), and serum total protein (TP) and albumin concentrations were lower, and age, mortality rate, frequency of common cold and pneumonia, COPD severity rankings, modified Medical Research Council (mMRC) dyspnea score, and proportions of patients with severe emphysema (>50% of low attenuation area) and receiving long-term oxygen therapy were higher than those in the nonexacerbation group (n=76). However, the proportion of patients with a greater number of eosinophils (≥200/μL and/or ≥2%) and the exhaled nitric oxide concentration did not differ between the two groups. In the univariate analysis, the risk factors for exacerbation were age; long-term oxygen therapy; low FVC, FEV, FEV/FVC and %FEV; high COPD severity ranking and mMRC score; severe emphysema; hypoproteinemia (<6.5 g/dL); hypoalbuminemia (<3.5 g/dL); leukocytosis; lymphocytopenia; and anemia. In the multivariate analysis, the risk factors were hypoalbuminemia, hypoproteinemia and low FEV. Additionally, in patients in the exacerbation-induced mortality subgroup, age, exacerbation frequency, mMRC score and the proportion of patients with lymphocytopenia were higher, and FVC, %FVC, FEV, serum TP concentration and the lymphocyte number were lower than those in the exacerbation survival subgroup.
Malnutrition, airflow limitation and severe emphysema were risks for exacerbation and mortality associated with infection in Japanese patients with COPD.
已报道西方和日本人群慢性阻塞性肺疾病(COPD)患者存在不同特征。COPD 加重的危险因素已在西方国家报道,但尚未在日本进行研究。
我们回顾性检查了 COPD 加重的危险因素。共纳入 156 例日本患者,分析了 136 例患者的记录。
在加重组(n=60)中,体重指数、用力肺活量(FVC)、一秒用力呼气量(FEV)、FEV/FVC 比值(FEV/FVC)、FEV 预计值百分比(%FEV)以及血清总蛋白(TP)和白蛋白浓度较低,年龄、死亡率、普通感冒和肺炎的频率、COPD 严重程度分级、改良医学研究委员会(mMRC)呼吸困难评分、严重肺气肿(>50%低衰减区)患者的比例和接受长期氧疗的比例高于非加重组(n=76)。然而,两组间嗜酸性粒细胞(≥200/μL 和/或≥2%)和呼气一氧化氮浓度的患者比例无差异。单因素分析显示,加重的危险因素为年龄、长期氧疗、FVC、FEV、FEV/FVC 和 %FEV 低、COPD 严重程度分级和 mMRC 评分高、严重肺气肿、低蛋白血症(<6.5 g/dL)、低白蛋白血症(<3.5 g/dL)、白细胞增多、淋巴细胞减少和贫血。多因素分析显示,危险因素为低白蛋白血症、低蛋白血症和 FEV 低。此外,在加重导致死亡亚组中,年龄、加重频率、mMRC 评分和淋巴细胞减少的患者比例较高,FVC、%FVC、FEV、血清 TP 浓度和淋巴细胞数量较低,与加重存活亚组相比。
在日本 COPD 患者中,营养不良、气流受限和严重肺气肿是与感染相关的加重和死亡的危险因素。